MedTrace Logo

Trial of Vitamin D Supplementation in Asthma

NCT00978315 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2014-02-04

No results posted yet for this study

Summary

The study null hypothesis is that vitamin D supplementation will not influence time to upper respiratory tract infection or time to severe asthma exacerbation in adult and adolescent patients with asthma.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cholecalciferol

Cholecalciferol will be administered as 2-monthly oral bolus doses of Vigantol oil over a period of one year

DIETARY_SUPPLEMENT

Miglyol oil

Miglyol oil will be administered as 2-monthly oral bolus doses of Vigantol oil over a period of one year

Sponsors & Collaborators

  • National Health Service, United Kingdom

    collaborator OTHER_GOV

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Adrian R Martineau, MRCP · Queen Mary University of London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00978315 on ClinicalTrials.gov